-
- HGH/HCG/DISP
- ACE-031/GRF(1-29)
- CJC1295/CJC1295 with DAC
- Gonadorelin/Follistatin 344
- GDF-8(myostatin)
- GHRP-2/GHRP-6
- Hexarelin/Iparmorelin
- HGH Frag 176-191
- IGF DES/IGF-1LR3/IGF-ILR3
- Melanotan Ⅰ/Melanotan Ⅱ
- MGF/Oxytocin/Retarutide
- PAL-GHK/PEG-MGF/PT141
- Selank/Sermorelin/Snap-8
- Tesamorelin/Triptorelin
- Thymosin Beta4(TB-500)
- Semaglutide/Tirzepatide
COMPANY PROFILE
Maintaining your health with professionalism
To convey the significance of health with the power of professionalism and warmth, and to help the public maintain their health in a more scientific way with medical concepts and technologies.
Established in 2018, BioEnzyme Innovations Ltd. is a high-tech enterprise located in Xiaoshan, Hangzhou, specializing in the production of animal-derived biopharmaceutical enzymes. The company takes "using genetic engineering technology to accelerate the development of innovative pharmaceutical products" as its business mission and "customer-centric, integrity as the cornerstone, and quality as the foundation" as the company's core values.
Putai Biotech has strictly passed and strictly implemented ISO9001 certification standards, and has a complete R&D, production and quality management system. The company has fermentation tanks with a tonnage or above and supporting equipment and facilities such as separation, purification, and verification, which can meet the needs of industrial customers.
Putai Biotech has strictly passed and strictly implemented ISO9001 certification standards, and has a complete R&D, production and quality management system. The company has fermentation tanks with a tonnage or above and supporting equipment and facilities such as separation, purification, and verification, which can meet the needs of industrial customers.
-
Hangzhou Putai Biotechnology Co., Ltd.
ABOUT US
Hangzhou Putai Biotechnology Co., Ltd., founded in 2018 and located in Xiaoshan, Hangzhou, is a high-tech enterprise specializing in animal-origin-free biopharmaceutical enzymes. Their mission is to accelerate pharmaceutical innovation using genetic engineering, with core values centered on customer focus, integrity, and quality.
Putai Bio adheres to ISO9001 standards, boasting a comprehensive R&D, production, and quality management system. Equipped with fermentation tanks and facilities for separation, purification, and verification, they meet industrial needs. Their product line includes recombinant enzymes like trypsin, enterokinase, lysine endonuclease, and carboxypeptidase B, as well as cytokines such as GM-CSF, G-CSF, and interferon.
The company emphasizes R&D and innovation, collaborating with universities like Zhejiang University. Since 2018, Putai Bio has secured 2 invention patents, 8 software copyrights, and 6 utility patents. Recognized as a “Eyas Plan” enterprise in Hangzhou, a “Small and Medium-sized Sci-Tech Enterprise” in Zhejiang in 2020, and a “National High-Tech Enterprise” in 2021, Putai Bio is committed to providing sustainable biological solutions and advancing the biopharmaceutical industry globally.
-
OUR PHILOSOPHY
Our development stems not only from our focus on the field of biopharmaceuticals, but also from our business philosophy, standardized management model and perfect operating system that enable others to achieve success.
Company purpose
①. Mission: Use genetic engineering technology to accelerate the development of innovative drug products.
② Core values: Customer-centered, integrity as the cornerstone, and quality as the foundation.
③. Spirit: Integrity, innovation, dedication and efficiency.
④Imagination: Continuously innovate and contribute to the development of the biomedical industry at home and abroad.Our philosophy
-
Our vision
We are committed to continuously promoting the implementation of innovative solutions in the field of biomedicine and helping customers deal with various medical problems. Looking to the future, we will continue to innovate, deeply integrate with advanced social productivity, and grow together with small and medium-sized enterprises in the process of change. We will always adhere to fulfilling our social responsibilities and make unremitting efforts to provide all-round support and assistance to small and medium-sized enterprises and jointly promote the sustainable development of the biopharmaceutical industry.
COMPANY VISION
PRODUCT CENTRE
CONTACT US